This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Bayer loses three-year Australian pharmaceutical patent clash against Sandoz

By James Panichi ( March 18, 2025, 08:41 GMT | Insight) -- A bitter clash between Bayer Intellectual Property and Swiss Pharmaceutical giant Sandoz AG over pharmaceutical patents has reached the end of the line in Australia, with the country’s supreme federal court shutting down Bayer’s last-ditch attempt to overturn a lower court’s ruling against the company. In a decision published this week, the High Court of Australia ruled that the application of Bayer, a German multinational, didn’t raise “an issue of principle sufficient to warrant a grant of special leave and the proposed appeal has insufficient prospect of success,” thus ending a legal showdown that began in December 2021.A bitter clash between Bayer Intellectual Property and Swiss Pharmaceutical giant Sandoz AG over pharmaceutical patents has reached the end of the line in Australia, with the country’s supreme federal court shutting down Bayer’s last-ditch attempt to overturn a lower court’s ruling against the company....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections